In non-small-cell lung cancer (NSCLC), clinical studies have shown that higher RANKL:OPG ratios in primary tumors are associated with an elevated risk of skeletal metastasis, emphasizing the prognostic significance of this axis [27]. The gene discussed is TNFRSF11B; the disease is non-small cell lung carcinoma.